This website is intended for healthcare professionals
This website is intended for healthcare professionals
The pharmacological pathway in the NICE guidelines on T2DM (NG28) is metformin as first line, or a choice of sulfonylurea (SU), pioglitazone, DPP-4 inhibitor, or SGLT-2 inhibitor if metformin not...
The main complications of diabetes are microvascular disease affecting the eyes, nerves and kidneys, and macrovascular disease leading to cardiovascular disease (CVD), cerebrovascular disease and...
The action of SGLT2 inhibitors is to reduce renal glucose and sodium reabsorption in the proximal tubule of the nephron resulting in increased urinary glucose excretion with osmotic and natriuretic...
Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.
Evidence-based best practice
Drug updates
Pharmacology information
Calculation skills